Wells Fargo’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.67M | Buy |
151,040
+118,278
| +361% | +$1.83M | ﹤0.01% | 3403 |
|
|
2025
Q4 | $667K | Buy |
32,762
+6,872
| +27% | +$121K | ﹤0.01% | 4262 |
|
|
2025
Q3 | $410K | Buy |
25,890
+3,945
| +18% | +$58.3K | ﹤0.01% | 4449 |
|
|
2025
Q2 | $293K | Buy |
21,945
+5,167
| +31% | +$69.8K | ﹤0.01% | 4515 |
|
|
2025
Q1 | $171K | Buy |
16,778
+1,570
| +10% | +$18.2K | ﹤0.01% | 4809 |
|
|
2024
Q4 | $241K | Buy |
15,208
+4,153
| +38% | +$216K | ﹤0.01% | 4679 |
|
|
2024
Q3 | $642K | Sell |
11,055
-464
| -4% | -$22.9K | ﹤0.01% | 3836 |
|
|
2024
Q2 | $526K | Buy |
11,519
+2,210
| +24% | +$119K | ﹤0.01% | 3883 |
|
|
2024
Q1 | $616K | Buy |
9,309
+3,363
| +57% | +$199K | ﹤0.01% | 3754 |
|
|
2023
Q4 | $236K | Sell |
5,946
-9,292
| -61% | -$291K | ﹤0.01% | 4370 |
|
|
2023
Q3 | $486K | Sell |
15,238
-6,085
| -29% | -$227K | ﹤0.01% | 3802 |
|
|
2023
Q2 | $857K | Buy |
21,323
+7,016
| +49% | +$308K | ﹤0.01% | 3574 |
|
|
2023
Q1 | $611K | Buy |
14,307
+14,260
| +30,340% | +$720K | ﹤0.01% | 3707 |
|
|
2022
Q4 | $2.26K | Sell |
47
-618
| -93% | -$28.9K | ﹤0.01% | 5986 |
|
|
2022
Q3 | $25K | Sell |
665
-3,512
| -84% | -$122K | ﹤0.01% | 5289 |
|
|
2022
Q2 | $115K | Buy |
4,177
+2,694
| +182% | +$118K | ﹤0.01% | 4564 |
|
|
2022
Q1 | $81K | Sell |
1,483
-5,351
| -78% | -$275K | ﹤0.01% | 5422 |
|
|
2021
Q4 | $400K | Buy |
6,834
+6,831
| +227,700% | +$341K | ﹤0.01% | 4838 |
|
|
2021
Q3 | $0 | Sell |
3
-6
| -67% | -$214 | ﹤0.01% | 7292 |
|
|
2021
Q2 | $0 | Sell |
9
-422
| -98% | -$22.9K | ﹤0.01% | 7212 |
|
|
2021
Q1 | $27K | Sell |
431
-19,083
| -98% | -$1.21M | ﹤0.01% | 6065 |
|
|
2020
Q4 | $1.38M | Buy |
19,514
+6,992
| +56% | +$441K | ﹤0.01% | 3782 |
|
|
2020
Q3 | $483K | Buy |
12,522
+499
| +4% | +$19.8K | ﹤0.01% | 4367 |
|
|
2020
Q2 | $451K | Buy |
+12,023
| New | +$370K | ﹤0.01% | 4404 |
|
Other funds holding KROS
NCM
VCM
O
VPM
MAP